Introductions, page-19

@RitzyBusiness for now I think the AGM video is probably the most accessible summary of RAC and Bisantrene's potential.

The question I personally have had come up the most when talking about RAC is some form of “If Bisantrene is so good why was it dropped?” Most people find it hard to believe that good drugs don’t always make it to market so there must be something wrong with Bisantrene, when in fact it is extremely common for good drugs to be dropped for all sorts of non-medical reasons. For every drug that makes it to market there must be a dozen drugs or more just as good that didn’t make it for one reason or another.